Article Details

Outlook Therapeutics, Inc. (NASDAQ:OTLK): Why Investors Shouldn't Ditch OTLK stock in 2021

Retrieved on: 2021-04-21 16:07:30

Tags for this article:

Click the tags to see associated articles and topics

Outlook Therapeutics, Inc. (NASDAQ:OTLK): Why Investors Shouldn't Ditch OTLK stock in 2021. View article details on hiswai:

Excerpt

There are 36 institutions holding the Outlook Therapeutics, Inc. stock share, with Vanguard Group, Inc. (The) the top institutional holder. As of Dec 30, ...

Article found on: marketingsentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up